PHK
LUNG icon

Point72 Hong Kong’s Pulmonx LUNG Stock Holding History

Point72 Hong Kong’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,613
Closed -$40K – 2212
2022
Q1 		$40K Buy
+1,613
New +$41.7K ﹤0.01% 1391
2021
Q4 		– Sell
-582
Closed -$21K – 2170
2021
Q3 		$21K Sell
582
-219
-27% -$8.62K ﹤0.01% 1696
2021
Q2 		$35K Buy
+801
New +$34.9K ﹤0.01% 1539

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Point72 Hong Kong's LUNG Position: Q2 2022 in Review

Point72 Hong Kong sold out of Pulmonx (LUNG) in Q2 2022, closing a stake of 1,613 shares — an estimated $40K sold.

Point72 Hong Kong first reported a position in LUNG in Q2 2021 and held it in 3 quarters. The position peaked at $40K in Q1 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2022.

  • Point72 Hong Kong reported no remaining Pulmonx position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,613 Pulmonx shares in Q2 2022, an estimated $40K.
  • Point72 Hong Kong first reported a position in Pulmonx in Q2 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Pulmonx position peaked at $40K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.